Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Leveringsproblemen medicijnen ziekte van Parkinson
okt 2018 | Bewegingsstoornissen